Sodium glycerophosphate, sold under the brand name Glycophos, is a medication used to supplement phosphate. It is administered via intravenous infusion. Sodium glycerophosphate is an organic phosphate salt. It was approved for medical use in Australia in November 2019. It is an unapproved medication in the United States that was used as a substitute during a drug shortage.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
foaf:depiction | |
dcterms:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage | |
Link from a Wikipage to an external page | |
sameAs | |
solubility |
|
dbp:wikiPageUsesTemplate | |
thumbnail | |
ATC suffix |
|
ATC prefix |
|
c |
|
CAS number |
|
ChEMBL |
|
ChemSpiderID |
|
DrugBank |
|
H |
|
IUPAC name |
|
KEGG |
|
melting high |
|
melting point |
|
na |
|
O |
|
p |
|
PubChem |
|
routes of administration | |
SMILES |
|
StdInChI |
|
StdInChIKey |
|
tradename |
|
UNII |
|
has abstract |
|
legal AU |
|
pregnancy AU comment |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
alternative name |
|
CAS number |
|
ChEMBL |
|
DrugBank |
|
FDA UNII code |
|
KEGG |
|
PubChem |
|
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage redirect of | |
is foaf:primaryTopic of |